Extensive & Unique
Tumour Profiling Assays Coverage from 50 to over 520 genes
Screens for genomics alterations and signatures
Accurate & Sensitive High accuracy at ≥5% limit of detection
Requiring betwen 10-20% tumour content
Personalized Actionable Reporting Report as per latest AMP & CAP guidelines
Recommendations based on clinical matching with biomarkers & clinical trials
